Aptevo Therapeutics (APVO) Misses Q3 EPS by 48c

Aptevo Therapeutics (NASDAQ: APVO) reported Q3 EPS of ($0.48).

For earnings history and earnings-related data on Aptevo Therapeutics (APVO) click here.

You May Also Be Interested In

• Circle Internet stock climbs on TD Cowen upgrade, Fed rate hike
• Boeing (BA) call put ratio 1.8 calls to 1 put into events
• Baidu (BIDU) call put ratio 5.7 calls to 1 put into President Donald Trump and Chinese President Xi Jinping's summit